サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1537077

インフルエンザワクチン市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測

Flu Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 195 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.70円
インフルエンザワクチン市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測
出版日: 2024年08月14日
発行: Persistence Market Research
ページ情報: 英文 195 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、インフルエンザワクチンの世界市場に関する包括的なレポートを発表しました。本レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • インフルエンザワクチン市場規模（2024E）：57億5,000万米ドル
  • 予測市場規模（2033F）：102億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：6.6%

インフルエンザワクチン市場- レポート範囲：

インフルエンザワクチンは、季節性インフルエンザを予防し、インフルエンザ流行の影響を軽減する上で重要な役割を果たしています。これらのワクチンは、様々なインフルエンザウイルス株に対する防御を提供し、公衆衛生に不可欠なものです。インフルエンザワクチン市場は、ヘルスケアプロバイダー、病院、診療所、公衆衛生機関を対象としており、3価ワクチンや4価ワクチン、複数のインフルエンザ株を標的とした新しい製剤など、さまざまなタイプのワクチンを提供しています。市場成長の原動力は、インフルエンザ予防に対する意識の高まり、ヘルスケア支出の増加、ワクチン技術の進歩によるワクチンの有効性と安全性の向上です。

市場成長の促進要因：

世界のインフルエンザワクチン市場は、季節性インフルエンザの予防やヘルスケア負担の軽減におけるワクチン接種の重要性に対する意識の高まりなど、いくつかの重要な要因によって推進されています。特に高齢者や幼児といった社会的弱者におけるインフルエンザ関連合併症の発生率の増加が、市場拡大のさらなる原動力となっています。高用量ワクチンやアジュバントワクチンの市場開拓といった技術の進歩は、予防効果を高め、市場の成長を刺激します。さらに、世界中の政府や保健機関によるワクチン接種プログラムの採用が増加していることも、インフルエンザワクチンに対する大きな需要を生み出しています。

市場抑制要因：

有望な成長見通しにもかかわらず、インフルエンザワクチン市場は、ワクチン接種のためらい、高い製造コスト、規制上のハードルに関する課題に直面しています。ワクチンの安全性や有効性に対する懸念がワクチン接種をためらわせ、ワクチン接種率や市場成長に影響を与える可能性があります。高い製造コストと複雑な製造工程は、特に中低所得国において、ワクチンの入手しやすさと購入しやすさに課題をもたらします。さらに、ワクチンの承認と流通に関する規制要件は、製造業者にとって業務上の複雑さをもたらし、市場力学に影響を与えています。

市場機会：

インフルエンザワクチン市場は、技術革新、人口動向、進化するヘルスケア提供モデルによって大きな成長機会がもたらされます。複数の株を標的とし、より長い予防効果を提供するワクチンなど、新しいワクチン製剤の市場開拓が市場の可能性を高めています。さらに、総合的なワクチン接種プログラムや公衆衛生イニシアティブとの提携など、予防衛生戦略におけるインフルエンザワクチンの適用拡大が、市場範囲を広げています。研究開発への戦略的投資は、ヘルスケアプロバイダーや政府機関との連携とともに、新たな機会を活用し、市場の成長を維持するために不可欠です。

本レポートで扱う主な質問

  • 世界のインフルエンザワクチン市場の成長を促す主な要因は何か？
  • 各地域でインフルエンザワクチンの採用に貢献しているワクチンの種類と製剤は何か？
  • 技術進歩はインフルエンザワクチン市場の競合情勢をどのように変えているのか？
  • インフルエンザワクチン市場に貢献している主要プレーヤーは誰で、市場の関連性を維持するためにどのような戦略をとっているのか？
  • 世界のインフルエンザワクチン市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 付加価値の洞察

  • 生産戦略
  • ボリューム消費
  • 生産コスト
  • パイプライン評価
  • 特許分析
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
  • 2024年の市場シナリオ

第7章 世界市場の（数量）分析

  • 市場（数量）分析、2019～2023年
  • 市場（数量）予測、2024～2033年
    • 前年比成長動向分析

第8章 世界市場- 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベル
    • ディストリビューターレベル
  • 世界平均価格分析ベンチマーク
    • 価格設定の前提

第9章 世界市場の需要（金額または規模）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 3価インフルエンザワクチン
    • 4価インフルエンザワクチン
  • 製品別市場の魅力分析

第11章 剤形別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 筋肉内注射
    • 鼻スプレー
    • 皮内注射
  • 剤形別市場の魅力分析

第12章 流通チャネル別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 機関投資家向け販売
      • 病院
      • コミュニティクリニック
      • 公衆衛生機関
      • 職場購買
    • 小売販売
      • 小売薬局
      • 通信販売薬局
  • 流通チャネル別市場の魅力分析

第13章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 東アジア市場分析

第18章 南アジア市場分析

第19章 オセアニア市場

第20章 中東・アフリカ市場分析

第21章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Sanofi Pasteur Inc.
    • Astrazeneca
    • Csl Ltd.
    • Abbbott
    • Glaxosmithkline Plc.
    • Serum Institute of India Pvt.Ltd

第23章 使用される仮定と頭字語

第24章 調査手法

目次
Product Code: PMRREP28720

Persistence Market Research has recently released a comprehensive report on the worldwide market for flu vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Flu Vaccines Market Size (2024E): USD 5.75 Billion
  • Projected Market Value (2033F): USD 10.2 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Flu Vaccines Market - Report Scope:

Flu vaccines play a crucial role in preventing seasonal influenza and reducing the impact of flu outbreaks. These vaccines are essential for public health, offering protection against various strains of influenza viruses. The flu vaccines market caters to healthcare providers, hospitals, clinics, and public health organizations, offering a range of vaccine types, including trivalent and quadrivalent vaccines, as well as newer formulations targeting multiple flu strains. Market growth is driven by increasing awareness of influenza prevention, rising healthcare expenditures, and advancements in vaccine technology, enhancing vaccine efficacy and safety.

Market Growth Drivers:

The global flu vaccines market is propelled by several key factors, including growing awareness about the importance of vaccination in preventing seasonal flu and reducing healthcare burdens. The increasing incidence of influenza-related complications, particularly among vulnerable populations such as the elderly and young children, further drives market expansion. Technological advancements, such as the development of high-dose and adjuvanted vaccines, offer improved protection and stimulate market growth. Additionally, the rising adoption of vaccination programs by governments and health organizations worldwide creates a substantial demand for flu vaccines.

Market Restraints:

Despite promising growth prospects, the flu vaccines market faces challenges related to vaccine hesitancy, high production costs, and regulatory hurdles. Vaccine hesitancy, driven by concerns about vaccine safety and efficacy, can impact vaccination rates and market growth. High production costs and complex manufacturing processes pose challenges for vaccine accessibility and affordability, particularly in low- and middle-income countries. Additionally, regulatory requirements for vaccine approval and distribution create operational complexities for manufacturers, affecting market dynamics.

Market Opportunities:

The flu vaccines market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new vaccine formulations, including those targeting multiple strains and offering longer protection, enhances market potential. Furthermore, the expanding application of flu vaccines in preventive health strategies, such as integrated vaccination programs and partnerships with public health initiatives, broadens market scope. Strategic investments in research and development, along with collaborations with healthcare providers and governmental agencies, are essential to capitalize on emerging opportunities and sustain market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the flu vaccines market globally?
  • Which vaccine types and formulations are contributing to the adoption of flu vaccines across different regions?
  • How are technological advancements reshaping the competitive landscape of the flu vaccines market?
  • Who are the key players contributing to the flu vaccines market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global flu vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global flu vaccines market, including GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, and AstraZeneca, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced vaccine formulations, including high-dose and adjuvanted vaccines, catering to diverse patient needs and public health requirements. Collaborations with governmental health agencies, public health organizations, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practices, and public education enhances market growth and vaccination uptake in the dynamic flu vaccines landscape.

Key Companies Profiled:

  • Sanofi Pasteur Inc.
  • AstraZeneca
  • Csl Ltd.
  • Abbott
  • GlaxoSmithKline Plc.
  • Serum Institute Of India Pvt.Ltd

Key Segments Covered in Flu Vaccines Industry Research

Product:

  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine

Dosage Form:

  • Intramuscular Injection
  • Nasal Spray
  • Intradermal Shot

Distribution Channel:

  • Institutional Sales
  • Retail Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Production Strategy
  • 4.2. Volume Consumption
  • 4.3. Production Cost
  • 4.4. Pipeline Assessment
  • 4.5. Patent Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Growing government support and focus for the development of the vaccines
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Development of Vaccine Products
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Expenditure on Research and Development
    • 5.2.4. Increasing Prevalence of Seasonal Flu
    • 5.2.5. Increased Vaccination Rates
    • 5.2.6. High Rate of Manufacturing
    • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Price Break up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
    • 8.3.1. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Trivalent Flu Vaccine
    • 10.3.2. Quadrivalent Flu Vaccine
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Dosage Form

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Dosage Form, 2024-2033
    • 11.3.1. Intramuscular Injection
    • 11.3.2. Nasal Spray
    • 11.3.3. Intradermal Shot
  • 11.4. Market Attractiveness Analysis By Dosage Form

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channels

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channels, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channels, 2024-2033
    • 12.3.1. Institutional Sales
      • 12.3.1.1. Hospitals
      • 12.3.1.2. Community Clinics
      • 12.3.1.3. Public Health Agencies
      • 12.3.1.4. Workplace Purchasing
    • 12.3.2. Retail Sales
      • 12.3.2.1. Retail Pharmacies
      • 12.3.2.2. Mail Order Pharmacies
  • 12.4. Market Attractiveness Analysis By Distribution Channels

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (Middle East and Africa)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Dosage Form
    • 14.3.4. By Distribution Channels
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Dosage Form
    • 14.4.4. By Distribution Channels
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Dosage Form
        • 14.8.1.2.3. By Distribution Channels
    • 14.8.2. Canada Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Dosage Form
        • 14.8.2.2.3. By Distribution Channels

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Dosage Form
    • 15.3.4. By Distribution Channels
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Dosage Form
    • 15.4.4. By Distribution Channels
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Dosage Form
        • 15.8.1.2.3. By Distribution Channels
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Dosage Form
        • 15.8.2.2.3. By Distribution Channels
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Dosage Form
        • 15.8.3.2.3. By Distribution Channels

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Dosage Form
    • 16.3.4. By Distribution Channels
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Dosage Form
    • 16.4.4. By Distribution Channels
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Dosage Form
        • 16.8.1.2.3. By Distribution Channels
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Dosage Form
        • 16.8.2.2.3. By Distribution Channels
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Dosage Form
        • 16.8.3.2.3. By Distribution Channels
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Dosage Form
        • 16.8.4.2.3. By Distribution Channels
    • 16.8.5. Spain Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Dosage Form
        • 16.8.5.2.3. By Distribution Channels
    • 16.8.6. BENELUX Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Dosage Form
        • 16.8.6.2.3. By Distribution Channels
    • 16.8.7. Russia Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Dosage Form
        • 16.8.7.2.3. By Distribution Channels

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Dosage Form
    • 17.3.4. By Distribution Channels
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Dosage Form
    • 17.4.4. By Distribution Channels
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Dosage Form
        • 17.8.1.2.3. By Distribution Channels
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Dosage Form
        • 17.8.2.2.3. By Distribution Channels
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Dosage Form
        • 17.8.3.2.3. By Distribution Channels

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Dosage Form
    • 18.3.4. By Distribution Channels
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Dosage Form
    • 18.4.4. By Distribution Channels
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Dosage Form
        • 18.8.1.2.3. By Distribution Channels
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Dosage Form
        • 18.8.2.2.3. By Distribution Channels
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Dosage Form
        • 18.8.3.2.3. By Distribution Channels
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Dosage Form
        • 18.8.4.2.3. By Distribution Channels

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Dosage Form
    • 19.3.4. By Distribution Channels
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Dosage Form
    • 19.4.4. By Distribution Channels
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Dosage Form
        • 19.8.1.2.3. By Distribution Channels
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Dosage Form
        • 19.8.2.2.3. By Distribution Channels

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Dosage Form
    • 20.3.4. By Distribution Channels
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Dosage Form
    • 20.4.4. By Distribution Channels
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Dosage Form
        • 20.8.1.2.3. By Distribution Channels
    • 20.8.2. Turkiye Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Dosage Form
        • 20.8.2.2.3. By Distribution Channels
    • 20.8.3. South Africa Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Dosage Form
        • 20.8.3.2.3. By Distribution Channels
    • 20.8.4. North Africa Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Dosage Form
        • 20.8.4.2.3. By Distribution Channels

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Sanofi Pasteur Inc.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
    • 22.3.2. Astrazeneca
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
    • 22.3.3. Csl Ltd.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
    • 22.3.4. Abbbott
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
    • 22.3.5. Glaxosmithkline Plc.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
    • 22.3.6. Serum Institute of India Pvt.Ltd
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology